nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexbrompheniramine—Orphenadrine—GRIN2D—schizophrenia	0.0123	0.124	CrCbGaD
Dexbrompheniramine—Doxylamine—CHRM1—schizophrenia	0.0096	0.096	CrCbGaD
Dexbrompheniramine—Captodiame—DRD3—schizophrenia	0.009	0.09	CrCbGaD
Dexbrompheniramine—Orphenadrine—GRIN1—schizophrenia	0.00834	0.0834	CrCbGaD
Dexbrompheniramine—Captodiame—HTR2C—schizophrenia	0.00755	0.0756	CrCbGaD
Dexbrompheniramine—Tolterodine—CHRM1—schizophrenia	0.00727	0.0728	CrCbGaD
Dexbrompheniramine—HRH1—Amine ligand-binding receptors—HTR7—schizophrenia	0.00684	0.00759	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—GRIN1—schizophrenia	0.00681	0.00756	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—GRIK3—schizophrenia	0.00678	0.00753	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—GAPDH—schizophrenia	0.00642	0.00713	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—TPH2—schizophrenia	0.0062	0.00689	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—SLC1A1—schizophrenia	0.00604	0.00671	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—DGKI—schizophrenia	0.00594	0.0066	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—CHRNB2—schizophrenia	0.00587	0.00652	CbGpPWpGaD
Dexbrompheniramine—HRH1—Monoamine GPCRs—HTR2A—schizophrenia	0.0057	0.00633	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—SLC17A7—schizophrenia	0.00553	0.00614	CbGpPWpGaD
Dexbrompheniramine—Brompheniramine—CHRM1—schizophrenia	0.00541	0.0541	CrCbGaD
Dexbrompheniramine—KCNH2—Hematopoietic Stem Cell Differentiation—IL1B—schizophrenia	0.00535	0.00595	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—CHRNA4—schizophrenia	0.00533	0.00592	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKI—schizophrenia	0.00531	0.0059	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—GRIK1—schizophrenia	0.00514	0.00571	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—CHRNA7—schizophrenia	0.00514	0.00571	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—HTR1A—schizophrenia	0.00513	0.0057	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—SLC6A4—schizophrenia	0.00496	0.00551	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—SNAP25—schizophrenia	0.00496	0.00551	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—GABRB2—schizophrenia	0.0049	0.00544	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—GAD2—schizophrenia	0.00483	0.00537	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—NTRK2—schizophrenia	0.00482	0.00536	CbGpPWpGaD
Dexbrompheniramine—HRH1—Amine ligand-binding receptors—HTR2A—schizophrenia	0.00479	0.00532	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—NEFL—schizophrenia	0.0047	0.00522	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—TH—schizophrenia	0.00442	0.00491	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—GRIK2—schizophrenia	0.00437	0.00485	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—NTS—schizophrenia	0.00429	0.00477	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—GRIN1—schizophrenia	0.00427	0.00475	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—SLC18A2—schizophrenia	0.00423	0.0047	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—CHRNA3—schizophrenia	0.00419	0.00465	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—GAD1—schizophrenia	0.00419	0.00465	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—SLC6A1—schizophrenia	0.00389	0.00433	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—GRIN2A—schizophrenia	0.00389	0.00433	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—GRIA1—schizophrenia	0.00389	0.00433	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—CAMK2B—schizophrenia	0.00389	0.00433	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—CACNB2—schizophrenia	0.00389	0.00433	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—schizophrenia	0.00384	0.00427	CbGpPWpGaD
Dexbrompheniramine—Chlorphenamine—SLC6A3—schizophrenia	0.00377	0.0377	CrCbGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—MAOA—schizophrenia	0.00373	0.00414	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—CHRNB2—schizophrenia	0.00369	0.0041	CbGpPWpGaD
Dexbrompheniramine—Mepyramine—CYP2D6—schizophrenia	0.00369	0.0369	CrCbGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—BDNF—schizophrenia	0.0036	0.004	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—CHRM1—schizophrenia	0.0035	0.00389	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—IL10—schizophrenia	0.00343	0.00382	CbGpPWpGaD
Dexbrompheniramine—Tripelennamine—CYP2D6—schizophrenia	0.00341	0.0341	CrCbGaD
Dexbrompheniramine—KCNH2—Neuronal System—CHRNA4—schizophrenia	0.00335	0.00372	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—MEF2C—schizophrenia	0.00334	0.00371	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—GRM5—schizophrenia	0.00325	0.00361	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—YWHAZ—schizophrenia	0.00323	0.00359	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAAR6—schizophrenia	0.00314	0.00349	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM1—schizophrenia	0.00313	0.00348	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—SNAP25—schizophrenia	0.00311	0.00346	CbGpPWpGaD
Dexbrompheniramine—Promazine—CHRM1—schizophrenia	0.00311	0.0311	CrCbGaD
Dexbrompheniramine—HRH1—IL-4 Signaling Pathway—FOS—schizophrenia	0.00307	0.00341	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—HSPA8—schizophrenia	0.00307	0.00341	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR6—schizophrenia	0.00306	0.0034	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—HTR2A—schizophrenia	0.00304	0.00338	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—CCK—schizophrenia	0.00298	0.00331	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GRM5—schizophrenia	0.00291	0.00323	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—DLG4—schizophrenia	0.00288	0.0032	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—CCKAR—schizophrenia	0.00285	0.00317	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—NTS—schizophrenia	0.00284	0.00316	CbGpPWpGaD
Dexbrompheniramine—Chlorphenamine—SLC6A4—schizophrenia	0.00282	0.0282	CrCbGaD
Dexbrompheniramine—KCNH2—Neuronal System—GRIN2B—schizophrenia	0.00281	0.00313	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—SLC6A3—schizophrenia	0.00277	0.00308	CbGpPWpGaD
Dexbrompheniramine—Promazine—DRD4—schizophrenia	0.00275	0.0275	CrCbGaD
Dexbrompheniramine—Tolterodine—CYP2D6—schizophrenia	0.00272	0.0272	CrCbGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—CHRM1—schizophrenia	0.0027	0.00301	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CCK—schizophrenia	0.00266	0.00296	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR6—schizophrenia	0.00262	0.00291	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CCKAR—schizophrenia	0.00255	0.00283	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—FZD3—schizophrenia	0.00255	0.00283	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—OXT—schizophrenia	0.00249	0.00277	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—GRM2—schizophrenia	0.00239	0.00266	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—TAAR6—schizophrenia	0.00239	0.00266	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—NPS—schizophrenia	0.00236	0.00263	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—COMT—schizophrenia	0.00236	0.00262	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—MAOA—schizophrenia	0.00234	0.0026	CbGpPWpGaD
Dexbrompheniramine—Carbinoxamine—CYP2D6—schizophrenia	0.00233	0.0233	CrCbGaD
Dexbrompheniramine—Promazine—DRD1—schizophrenia	0.00233	0.0233	CrCbGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—HTR2C—schizophrenia	0.00232	0.00258	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CHRM1—schizophrenia	0.00232	0.00257	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—schizophrenia	0.00223	0.00248	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—CCKAR—schizophrenia	0.0022	0.00245	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—NTS—schizophrenia	0.00216	0.00241	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—ADORA2A—schizophrenia	0.00214	0.00238	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—schizophrenia	0.00211	0.00235	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—schizophrenia	0.00207	0.0023	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—GRM3—schizophrenia	0.00204	0.00226	CbGpPWpGaD
Dexbrompheniramine—HRH1—IL-4 Signaling Pathway—EP300—schizophrenia	0.00203	0.00226	CbGpPWpGaD
Dexbrompheniramine—Brompheniramine—CYP2D6—schizophrenia	0.00202	0.0202	CrCbGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—HTR6—schizophrenia	0.002	0.00222	CbGpPWpGaD
Dexbrompheniramine—Promazine—HTR2C—schizophrenia	0.00199	0.0199	CrCbGaD
Dexbrompheniramine—Chlorphenamine—CYP2D6—schizophrenia	0.00198	0.0198	CrCbGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCK—schizophrenia	0.00197	0.00219	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1B—schizophrenia	0.00193	0.00214	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCKAR—schizophrenia	0.00189	0.0021	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1A—schizophrenia	0.00186	0.00206	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADORA2A—schizophrenia	0.00183	0.00204	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—IL1B—schizophrenia	0.0018	0.002	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2C—schizophrenia	0.00179	0.00199	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—schizophrenia	0.00179	0.00199	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—CHRM1—schizophrenia	0.00176	0.00196	CbGpPWpGaD
Dexbrompheniramine—Diphenhydramine—CYP1A2—schizophrenia	0.00174	0.0174	CrCbGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—schizophrenia	0.00174	0.00193	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—NPY—schizophrenia	0.00171	0.0019	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—DGKI—schizophrenia	0.00169	0.00188	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—schizophrenia	0.00168	0.00187	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1B—schizophrenia	0.00165	0.00183	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—OXT—schizophrenia	0.00165	0.00183	CbGpPWpGaD
Dexbrompheniramine—Promazine—DRD2—schizophrenia	0.00164	0.0164	CrCbGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—GRM5—schizophrenia	0.00164	0.00182	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—EP300—schizophrenia	0.00161	0.00179	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—CNR1—schizophrenia	0.00161	0.00179	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1A—schizophrenia	0.00159	0.00177	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR7—schizophrenia	0.00157	0.00174	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—schizophrenia	0.00157	0.00174	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—NPS—schizophrenia	0.00157	0.00174	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—DGKI—schizophrenia	0.00154	0.00171	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—schizophrenia	0.00154	0.00171	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2C—schizophrenia	0.00154	0.00171	CbGpPWpGaD
Dexbrompheniramine—Promazine—CYP1A2—schizophrenia	0.0015	0.015	CrCbGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—CCK—schizophrenia	0.0015	0.00167	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—schizophrenia	0.00149	0.00165	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—schizophrenia	0.00144	0.0016	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—CCKAR—schizophrenia	0.00144	0.0016	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—HTR2A—schizophrenia	0.00142	0.00158	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—PPP1R1B—schizophrenia	0.00141	0.00156	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—ADORA2A—schizophrenia	0.00139	0.00155	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CNR1—schizophrenia	0.00138	0.00153	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—GRM2—schizophrenia	0.00135	0.0015	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—TAAR6—schizophrenia	0.00135	0.0015	CbGpPWpGaD
Dexbrompheniramine—Diphenhydramine—CYP2D6—schizophrenia	0.00135	0.0135	CrCbGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—schizophrenia	0.00134	0.00149	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR7—schizophrenia	0.00134	0.00149	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—TNF—schizophrenia	0.00131	0.00145	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—FZD3—schizophrenia	0.00131	0.00145	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—NPY—schizophrenia	0.0013	0.00145	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—schizophrenia	0.00127	0.00141	CbGpPWpGaD
Dexbrompheniramine—Promazine—HTR2A—schizophrenia	0.00127	0.0127	CrCbGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—HTR1B—schizophrenia	0.00126	0.0014	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—OXT—schizophrenia	0.00126	0.0014	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—NGEF—schizophrenia	0.00125	0.00139	CbGpPWpGaD
Dexbrompheniramine—HRH1—IL-4 Signaling Pathway—AKT1—schizophrenia	0.00123	0.00137	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—PPP3CC—schizophrenia	0.00123	0.00136	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—GRM2—schizophrenia	0.00123	0.00136	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—TAAR6—schizophrenia	0.00123	0.00136	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—NTS—schizophrenia	0.00122	0.00136	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—HTR1A—schizophrenia	0.00121	0.00134	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—NPS—schizophrenia	0.00119	0.00132	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—DRD1—schizophrenia	0.00117	0.0013	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—HTR2C—schizophrenia	0.00117	0.0013	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—GRM3—schizophrenia	0.00115	0.00128	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—RGS4—schizophrenia	0.00115	0.00128	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—NGEF—schizophrenia	0.00114	0.00126	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—DRD3—schizophrenia	0.00113	0.00126	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—HTR6—schizophrenia	0.00113	0.00125	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—NTS—schizophrenia	0.00111	0.00123	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—schizophrenia	0.0011	0.00122	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—DRD4—schizophrenia	0.0011	0.00122	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—CNR1—schizophrenia	0.00105	0.00117	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—GRM3—schizophrenia	0.00104	0.00116	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—RGS4—schizophrenia	0.00104	0.00116	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—HTR6—schizophrenia	0.00103	0.00114	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—DRD2—schizophrenia	0.00102	0.00114	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—HTR7—schizophrenia	0.00102	0.00114	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—CHRM1—schizophrenia	0.000997	0.00111	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—IL3RA—schizophrenia	0.000972	0.00108	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—schizophrenia	0.000942	0.00105	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—GRM5—schizophrenia	0.000927	0.00103	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—DGKI—schizophrenia	0.000908	0.00101	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—CHRM1—schizophrenia	0.000906	0.00101	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—IL3RA—schizophrenia	0.000883	0.000981	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—CCK—schizophrenia	0.000848	0.000942	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—GRM5—schizophrenia	0.000842	0.000935	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—PPP1R1B—schizophrenia	0.00083	0.000922	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—PDE4B—schizophrenia	0.000826	0.000918	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—CCKAR—schizophrenia	0.000813	0.000903	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—ADORA2A—schizophrenia	0.000788	0.000876	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—FZD3—schizophrenia	0.000772	0.000858	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—CCK—schizophrenia	0.00077	0.000856	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—PDE4B—schizophrenia	0.00075	0.000834	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—CCKAR—schizophrenia	0.000738	0.00082	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—NPY—schizophrenia	0.000737	0.000818	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—PPP3CC—schizophrenia	0.000726	0.000806	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—GRM2—schizophrenia	0.000726	0.000806	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—FES—schizophrenia	0.000726	0.000806	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—TAAR6—schizophrenia	0.000726	0.000806	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—HTR2A—schizophrenia	0.000717	0.000797	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—ADORA2A—schizophrenia	0.000716	0.000795	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—HTR1B—schizophrenia	0.000711	0.00079	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—OXT—schizophrenia	0.000711	0.00079	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—HTR1A—schizophrenia	0.000684	0.00076	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—NPS—schizophrenia	0.000674	0.000748	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—NGEF—schizophrenia	0.000671	0.000746	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—NPY—schizophrenia	0.000669	0.000743	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—HTR2C—schizophrenia	0.000661	0.000734	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—DRD1—schizophrenia	0.000661	0.000734	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—NTS—schizophrenia	0.000656	0.000729	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—HTR1B—schizophrenia	0.000645	0.000717	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—OXT—schizophrenia	0.000645	0.000717	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—DRD3—schizophrenia	0.00064	0.000711	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—HTR1A—schizophrenia	0.000621	0.00069	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—DRD4—schizophrenia	0.000621	0.00069	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—RGS4—schizophrenia	0.000617	0.000686	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—GRM3—schizophrenia	0.000617	0.000686	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—RTN4—schizophrenia	0.000617	0.000686	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—NPS—schizophrenia	0.000612	0.00068	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—HTR6—schizophrenia	0.000606	0.000673	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—DRD1—schizophrenia	0.0006	0.000667	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—HTR2C—schizophrenia	0.0006	0.000667	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—CNR1—schizophrenia	0.000593	0.000659	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—MAG—schizophrenia	0.000585	0.00065	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—DRD3—schizophrenia	0.000581	0.000646	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—DRD2—schizophrenia	0.000579	0.000643	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—HTR7—schizophrenia	0.000579	0.000643	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—DRD4—schizophrenia	0.000564	0.000627	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—CNR1—schizophrenia	0.000539	0.000598	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—CHRM1—schizophrenia	0.000535	0.000594	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—DRD2—schizophrenia	0.000525	0.000584	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—HTR7—schizophrenia	0.000525	0.000584	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—IL3RA—schizophrenia	0.000521	0.000579	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—TLE1—schizophrenia	0.000509	0.000565	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—NRG3—schizophrenia	0.000509	0.000565	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—GFAP—schizophrenia	0.000503	0.000559	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—GRM5—schizophrenia	0.000497	0.000553	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—TLE3—schizophrenia	0.000482	0.000535	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—CCK—schizophrenia	0.000455	0.000505	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—PDE4B—schizophrenia	0.000443	0.000493	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—CCKAR—schizophrenia	0.000436	0.000485	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—ADORA2A—schizophrenia	0.000423	0.00047	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—PLA2G4A—schizophrenia	0.000416	0.000462	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—FGA—schizophrenia	0.000405	0.00045	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—HTR2A—schizophrenia	0.000405	0.00045	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—NPY—schizophrenia	0.000395	0.000439	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—NOTCH4—schizophrenia	0.000395	0.000439	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—ATP2A2—schizophrenia	0.000395	0.000439	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—OXT—schizophrenia	0.000381	0.000424	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—HTR1B—schizophrenia	0.000381	0.000424	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—HTR2A—schizophrenia	0.000368	0.000409	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—HTR1A—schizophrenia	0.000367	0.000408	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—NPS—schizophrenia	0.000361	0.000402	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—HTR2C—schizophrenia	0.000354	0.000394	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—DRD1—schizophrenia	0.000354	0.000394	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—NTRK2—schizophrenia	0.000345	0.000383	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—DRD3—schizophrenia	0.000343	0.000381	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—DRD4—schizophrenia	0.000333	0.00037	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—CNR1—schizophrenia	0.000318	0.000353	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—HTR7—schizophrenia	0.00031	0.000345	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—DRD2—schizophrenia	0.00031	0.000345	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—PRL—schizophrenia	0.000293	0.000326	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—S100B—schizophrenia	0.000273	0.000304	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—ERBB4—schizophrenia	0.000261	0.00029	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—PLA2G4A—schizophrenia	0.000246	0.000273	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—NRG1—schizophrenia	0.000241	0.000268	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—MEF2C—schizophrenia	0.000239	0.000265	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—YWHAZ—schizophrenia	0.000231	0.000257	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—ERBB3—schizophrenia	0.000226	0.000251	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—HTR2A—schizophrenia	0.000217	0.000242	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—APOE—schizophrenia	0.000202	0.000225	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—APOA1—schizophrenia	0.0002	0.000222	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—ESR1—schizophrenia	0.000193	0.000214	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—GSK3B—schizophrenia	0.000175	0.000194	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—AKT1—schizophrenia	0.00013	0.000144	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—AKT1—schizophrenia	0.000118	0.000131	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—EP300—schizophrenia	0.000115	0.000128	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—TP53—schizophrenia	8.24e-05	9.16e-05	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—AKT1—schizophrenia	6.96e-05	7.73e-05	CbGpPWpGaD
